GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ginwa Enterprise Group Inc (SHSE:600080) » Definitions » Other Financing

Ginwa Enterprise Group (SHSE:600080) Other Financing : ¥-158.3 Mil (TTM As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Ginwa Enterprise Group Other Financing?

Ginwa Enterprise Group's Other Financing for the three months ended in Sep. 2024 was ¥0.0 Mil.

Ginwa Enterprise Group's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-158.3 Mil.

Ginwa Enterprise Group Other Financing Historical Data

The historical data trend for Ginwa Enterprise Group's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginwa Enterprise Group Other Financing Chart

Ginwa Enterprise Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.00 - - - -7.49

Ginwa Enterprise Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.68 -0.80 -127.04 -30.44 -

Ginwa Enterprise Group Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-158.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginwa Enterprise Group Other Financing Related Terms

Thank you for viewing the detailed overview of Ginwa Enterprise Group's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginwa Enterprise Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ginwa Enterprise Group Inc (SHSE:600080) » Definitions » Other Financing
Comparable Companies
SZSE:002864 SZSE:301520 SZSE:000153 SHSE:603538 SHSE:600594 SZSE:300452 SHSE:688117 SHSE:600513 SZSE:300683 SZSE:002940 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Website
http://www.ginwa.com
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
Executives
Zhang Chao Yang Director
Zhang Mei Director
Tao Yu senior management
Qin Chuan Director
Hou Yi Wen senior management
Ge Xiu Li Supervisors

Ginwa Enterprise Group Headlines

No Headlines